Clinical phase III trials of the Bharat Biotech's COVID-19 nasal vaccine completed
October 5, 2026
  • Read Ecopy
  • Circulation
  • Advertise
  • Careers
  • About Us
  • Contact Us
Android AppiPhone AppArattai
Organiser
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • World Hindu Congress 2026
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
  • ‌
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Europe
    • North America
    • South America
    • Africa
    • Australia
  • Editorial
  • International
  • Opinion
  • RSS @ 100
  • More
    • World Hindu Congress 2026
    • Op Sindoor
    • Analysis
    • Sports
    • Defence
    • Politics
    • Business
    • Economy
    • Culture
    • Special Report
    • Sci & Tech
    • Entertainment
    • G20
    • Azadi Ka Amrit Mahotsav
    • Vocal4Local
    • Web Stories
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Law
    • Health
    • Obituary
  • Subscribe
    • Subscribe Print Edition
    • Subscribe Ecopy
    • Read Ecopy
Organiser
  • Home
  • Bharat
  • World
  • Operation Sindoor
  • Editorial
  • Analysis
  • Opinion
  • Culture
  • Defence
  • International Edition
  • RSS @ 100
  • Magazine
  • Read Ecopy
Home Bharat

Clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine completed

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France.

WEBDESKWEBDESK
Jun 19, 2022, 12:20 pm IST
inBharat
Follow on Google News
Facebook
Twitter
WhatsAppTelegramEmail

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month.

In an exclusive interview with ANI, Dr Ella said, “We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world’s first clinically proven nasal COVID-19 vaccine”.

Krishna was in Paris as a speaker at Viva Technology 2022 where India was declared country of the year. India’s drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its COVID-19 nasal vaccine. On the booster dose of COVID-19, Krishna said that those who had taken the second dose must take the booster dose.

“Booster dose of vaccine gives immunity. I always say the booster dose is a miracle dose for every vaccination. Even in children first, two doses don’t give much immunity, but the third dose gives an amazing response to the child. The same thing for adults also. The third dose is very important for adults. COVID-19 can’t be eradicated 100 per cent. It will be there and we have to live with it and handle it and more intelligently how to control it,” he said.

Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France. “I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997.”

He said that earlier United States was the centre of startups but for the first time Indians are getting exposure in France. “I am so happy to say the French government is very practical. They are really encouraging India and with truthfully a good heart. Again, they are really pushing how more the government can work together. How about the country’s startups can work together?”, he said.

“How government policies can create an ecosystem that is scalable, even French President Macron was talking about how to scale it up between the two partnerships, how to scale up for globe and the digitalization all that is talking about infrastructure, digitalization all that they are talking and that is a good sign between the two countries and the first time French is coming closer to India,” he added.

 

Topics: COVID-19Bharat BiotechCOVID vaccineIndia
Share
Tweet
SendShareSend
✮ Subscribe Organiser YouTube Channel. ✮
✮ Join Organiser's WhatsApp channel for Nationalist views beyond the news. ✮
Previous News

PM Modi inaugurates Pragati Maidan Integrated Transit Corridor project in Delhi

Next News

Lok Sabha speaker Om Birla completes 3 years in office; Lok Sabha saves Rs 668.86 crore

Related News

Principal Secretary-2 to Prime Minister Shaktikanta Das

India to Build Rare-Earth Magnets: Shaktikanta Das hails self-reliance amid China’s restrictions & supply chain shocks

Central Coalfields Transforming Itself for a New India

From 50 MT to 87.5 MT: How central coalfields rebuilt itself for a new India!

AI Generated Image

Beyond ‘Vote Chori’: Ten facts on SIR, electoral rolls and the Election Commission of India

When festivities find a greener way to celebrate!

ECI controversy resembles Bangladesh regime change playbook; Is it a CIA conspiracy to destabilise India?

Narco kingpin Navpreet Singh deported to India from Turkey; Amit Shah vows destruction of drug menace by 2029

Load More

Latest News

RSS Sarkaryavah Dattatreya Hosabale addressing the Ram-Sharad Kothari Pratibha Samman 2026 in Kolkata, reflected on preserving the Kothari brothers’ legacy through service and dedication

Ram-Sharad Kothari Pratibha Samman 2026| Inspiration for constructive work: Dattatreya Hosabale

British Airways jet declares emergency over Ireland after 28,000-foot descent, turns back to Heathrow, London

Viral Video Claims Oslo, Soros Links & Timeline Raise Questions Over CJP — ‘Organic’ Gen-Z Uprising Scripted Abroad?

Viral Video Claims Oslo, Soros Links & Timeline Raise Questions Over CJP — ‘Organic’ Gen-Z Uprising Scripted Abroad?

PM E-DRIVE has accelerated India’s EV transition by supporting mass mobility, electric buses, charging infrastructure

PM E-DRIVE: How India’s EV scheme is driving mass mobility, domestic manufacturing & self-reliance

Representative Image

Beyond Gen Z and Gen Alpha Labels: Understanding Children, respecting diversities & keeping generations connected!

Representative Image

Dehradun Gym owner Mohammad Armaan arrested over betrayal, blackmail; Hindu deity slurs trigger outrage

On dias, from left: Alok Kumar, International President, Vishwa Hindu Parishad, Mahesh Bhagchandka, Converner, Ashok Singhal Foundation, Amit Shah, Union Home Minister, Dattatreya Hosabale, Sarkaryavah, Rashtriya Swayamsevak Sangh and Swami Paramanand Giri JI Maharaj

Ashok ji Singhal: Social bridge-builder through Sri Ram

Representative Image

J&K: 150 Bangladeshi nationals deported during verification drive; Illegal migrants handed over to BSF in Bagdogra

UPSC NDA 2 Result 2026 is expected to be announced by the second week of October, with the result PDF containing the roll numbers of qualified candidates

NDA 2 Result 2026: When will UPSC declare NDA & NA II result? Check expected date and timeline

Rajya Sabha Elections: BJP releases list for Uttar Pradesh; New faces reflect regional balance

Load More
  • Privacy
  • Terms
  • Cookie Policy
  • Refund and Cancellation
  • Delivery and Shipping

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies

  • Home
  • Search Organiser
  • Bharat
    • Assam
    • Bihar
    • Chhattisgarh
    • Jharkhand
    • Maharashtra
    • View All States
  • World
    • Asia
    • Africa
    • North America
    • South America
    • Europe
    • Australia
  • Editorial
  • Operation Sindoor
  • Opinion
  • Analysis
  • Defence
  • Culture
  • Sports
  • Business
  • RSS @ 100
  • Entertainment
  • More ..
    • Sci & Tech
    • Vocal4Local
    • Special Report
    • Education
    • Employment
    • Books
    • Interviews
    • Travel
    • Health
    • Politics
    • Law
    • Economy
    • Obituary
  • Subscribe Magazine
  • Read Ecopy
  • Advertise
  • Circulation
  • Careers
  • About Us
  • Contact Us
  • Policies & Terms
    • Privacy Policy
    • Cookie Policy
    • Refund and Cancellation
    • Terms of Use

© Bharat Prakashan (Delhi) Limited.
Tech-enabled by Ananthapuri Technologies